The fertility test market size is expected to develop at a CAGR of 7.9% during the projected period. The growing awareness about infertility and the need for early detection is increasing the sales of fertility test kits. As a result, the market value is projected to increase from US$ 548.4 million in 2024 to US$ 1.2 billion by 2034.
Fertility Test Market Insights and Analysis
Attributes | Details |
---|---|
Estimated Market Size in 2024 | US$ 548.4 million |
Forecasted Market Size by 2034 | US$ 1.2 billion |
Projected Value CAGR (2024 to 2034) | 7.9% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The demand for home-based fertility testing kits is on the rise. These kits are cost-effective and offer convenience to users, making them an attractive option for those who prefer to assess their fertility levels in the privacy of their homes. As a result, many companies are focusing on developing innovative and accurate home-based testing kits to meet this demand.
The rise of digital health technology is also creating new opportunities for market players in the fertility testing market. Mobile apps, wearables, and other digital health tools are gaining popularity among consumers. Many companies are developing fertility testing products that can be integrated with these tools.
This integration allows for a more personalized approach to fertility testing, potentially leading to better outcomes for users. Companies that can develop innovative and accurate fertility testing products catering to these trends are likely to be well-positioned for success in this market.
The ovulation prediction kit segment dominates the market by product and is projected to maintain its dominance through 2034, registering a 7.7% CAGR. The saliva segment leads the market in terms of the sample category. This segment is expected to record a CAGR of 7.4% during the forecast period.
Attributes | Details |
---|---|
Product | Ovulation prediction kit |
Forecasted CAGR From 2024 to 2034 | 7.7% |
The market is significantly influenced by the dominance of the ovulation prediction kit segment, supported by the following points:
Attributes | Details |
---|---|
By Sample | Saliva |
Forecasted CAGR from 2024 to 2034 | 7.4% |
The market is led by the saliva segment within the sample category, a fact reinforced by the following:
Countries | Forecasted CAGR from 2024 to 2034 |
---|---|
United States | 7.6% |
United Kingdom | 9.1% |
China | 8.7% |
Japan | 9.3% |
South Korea | 9.8% |
The increasing awareness among people about their reproductive health in the United States is a primary factor contributing to its dominance in the fertility test market. Other supporting factors include:
The fertility test market in the United Kingdom holds significant growth potential. Factors backing up this growth are:
The demand for fertility testing is considerable in China. This growth in the fertility test market can be attributed to the following factors:
The rise in demand for fertility tests in Japan can be attributed to the country's strict regulations on assisted reproductive technologies. In addition to this, there are several other reasons supporting the expansion of the fertility test market:
The adoption rate of fertility tests in South Korea is significantly higher than in other Asian countries, and this trend is anticipated to continue in the upcoming years. This trend is supported by:
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The fertility test market is highly competitive, with several players offering a range of products and services. These companies provide various fertility tests, ranging from prediction kits to sperm count tests. Additionally, several new players in the market are leveraging technology such as artificial intelligence and machine learning to develop advanced fertility testing solutions.
Recent Developments
The market in China is expected to progress at a CAGR of 8.7% through the forecast period.
The market is currently valued at around US$ 548.4 million in 2024.
Within the product segment, the ovulation prediction kit segment contributes the most to the market.
The United States dominates the market, exhibiting a 9.1% CAGR from 2024 to 2034.
The market is set to reach a valuation of around US$ 1.2 billion by 2034.
The market is forecasted to register a CAGR of 7.9% through 2034.
Demand for fertility tests increased at a 9.5% CAGR from 2019 to 2023.
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Investment Feasibility Matrix
3.5. PESTLE and Porter’s Analysis
3.6. Regulatory Landscape
3.6.1. By Key Regions
3.6.2. By Key Countries
3.7. Regional Parent Market Outlook
4. Global Market Analysis 2019 to 2023 and Forecast, 2024 to 2034
4.1. Historical Market Size Value (US$ Million) Analysis, 2019 to 2023
4.2. Current and Future Market Size Value (US$ Million) Projections, 2024 to 2034
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Product
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Million) Analysis By Product, 2019 to 2023
5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Product, 2024 to 2034
5.3.1. Ovulation prediction kit
5.3.2. Male fertility testing products
5.3.3. Fertility monitor
5.3.4. Others
5.4. Y-o-Y Growth Trend Analysis By Product, 2019 to 2023
5.5. Absolute $ Opportunity Analysis By Product, 2024 to 2034
6. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Sample
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Million) Analysis By Sample, 2019 to 2023
6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Sample, 2024 to 2034
6.3.1. Saliva
6.3.2. Blood
6.3.3. Urine
6.3.4. Others
6.4. Y-o-Y Growth Trend Analysis By Sample, 2019 to 2023
6.5. Absolute $ Opportunity Analysis By Sample, 2024 to 2034
7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Mode of Purchase
7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ Million) Analysis By Mode of Purchase, 2019 to 2023
7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Mode of Purchase, 2024 to 2034
7.3.1. Over the counter
7.3.2. Prescription based
7.4. Y-o-Y Growth Trend Analysis By Mode of Purchase, 2019 to 2023
7.5. Absolute $ Opportunity Analysis By Mode of Purchase, 2024 to 2034
8. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Application
8.1. Introduction / Key Findings
8.2. Historical Market Size Value (US$ Million) Analysis By Application, 2019 to 2023
8.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Application, 2024 to 2034
8.3.1. Female
8.3.2. Male
8.4. Y-o-Y Growth Trend Analysis By Application, 2019 to 2023
8.5. Absolute $ Opportunity Analysis By Application, 2024 to 2034
9. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By End User
9.1. Introduction / Key Findings
9.2. Historical Market Size Value (US$ Million) Analysis By End User, 2019 to 2023
9.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End User, 2024 to 2034
9.3.1. Hospitals
9.3.2. Homecare settings
9.3.3. Fertility clinics
9.3.4. Others'
9.4. Y-o-Y Growth Trend Analysis By End User, 2019 to 2023
9.5. Absolute $ Opportunity Analysis By End User, 2024 to 2034
10. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Region
10.1. Introduction
10.2. Historical Market Size Value (US$ Million) Analysis By Region, 2019 to 2023
10.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2024 to 2034
10.3.1. North America
10.3.2. Latin America
10.3.3. Western Europe
10.3.4. Eastern Europe
10.3.5. South Asia and Pacific
10.3.6. East Asia
10.3.7. Middle East and Africa
10.4. Market Attractiveness Analysis By Region
11. North America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023
11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034
11.2.1. By Country
11.2.1.1. USA
11.2.1.2. Canada
11.2.2. By Product
11.2.3. By Sample
11.2.4. By Mode of Purchase
11.2.5. By Application
11.2.6. By End User
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Product
11.3.3. By Sample
11.3.4. By Mode of Purchase
11.3.5. By Application
11.3.6. By End User
11.4. Key Takeaways
12. Latin America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023
12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034
12.2.1. By Country
12.2.1.1. Brazil
12.2.1.2. Mexico
12.2.1.3. Rest of Latin America
12.2.2. By Product
12.2.3. By Sample
12.2.4. By Mode of Purchase
12.2.5. By Application
12.2.6. By End User
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Product
12.3.3. By Sample
12.3.4. By Mode of Purchase
12.3.5. By Application
12.3.6. By End User
12.4. Key Takeaways
13. Western Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023
13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034
13.2.1. By Country
13.2.1.1. Germany
13.2.1.2. UK
13.2.1.3. France
13.2.1.4. Spain
13.2.1.5. Italy
13.2.1.6. Rest of Western Europe
13.2.2. By Product
13.2.3. By Sample
13.2.4. By Mode of Purchase
13.2.5. By Application
13.2.6. By End User
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Product
13.3.3. By Sample
13.3.4. By Mode of Purchase
13.3.5. By Application
13.3.6. By End User
13.4. Key Takeaways
14. Eastern Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023
14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034
14.2.1. By Country
14.2.1.1. Poland
14.2.1.2. Russia
14.2.1.3. Czech Republic
14.2.1.4. Romania
14.2.1.5. Rest of Eastern Europe
14.2.2. By Product
14.2.3. By Sample
14.2.4. By Mode of Purchase
14.2.5. By Application
14.2.6. By End User
14.3. Market Attractiveness Analysis
14.3.1. By Country
14.3.2. By Product
14.3.3. By Sample
14.3.4. By Mode of Purchase
14.3.5. By Application
14.3.6. By End User
14.4. Key Takeaways
15. South Asia and Pacific Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
15.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023
15.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034
15.2.1. By Country
15.2.1.1. India
15.2.1.2. Bangladesh
15.2.1.3. Australia
15.2.1.4. New Zealand
15.2.1.5. Rest of South Asia and Pacific
15.2.2. By Product
15.2.3. By Sample
15.2.4. By Mode of Purchase
15.2.5. By Application
15.2.6. By End User
15.3. Market Attractiveness Analysis
15.3.1. By Country
15.3.2. By Product
15.3.3. By Sample
15.3.4. By Mode of Purchase
15.3.5. By Application
15.3.6. By End User
15.4. Key Takeaways
16. East Asia Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
16.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023
16.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034
16.2.1. By Country
16.2.1.1. China
16.2.1.2. Japan
16.2.1.3. South Korea
16.2.2. By Product
16.2.3. By Sample
16.2.4. By Mode of Purchase
16.2.5. By Application
16.2.6. By End User
16.3. Market Attractiveness Analysis
16.3.1. By Country
16.3.2. By Product
16.3.3. By Sample
16.3.4. By Mode of Purchase
16.3.5. By Application
16.3.6. By End User
16.4. Key Takeaways
17. Middle East and Africa Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
17.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023
17.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034
17.2.1. By Country
17.2.1.1. GCC Countries
17.2.1.2. South Africa
17.2.1.3. Israel
17.2.1.4. Rest of MEA
17.2.2. By Product
17.2.3. By Sample
17.2.4. By Mode of Purchase
17.2.5. By Application
17.2.6. By End User
17.3. Market Attractiveness Analysis
17.3.1. By Country
17.3.2. By Product
17.3.3. By Sample
17.3.4. By Mode of Purchase
17.3.5. By Application
17.3.6. By End User
17.4. Key Takeaways
18. Key Countries Market Analysis
18.1. USA
18.1.1. Pricing Analysis
18.1.2. Market Share Analysis, 2023
18.1.2.1. By Product
18.1.2.2. By Sample
18.1.2.3. By Mode of Purchase
18.1.2.4. By Application
18.1.2.5. By End User
18.2. Canada
18.2.1. Pricing Analysis
18.2.2. Market Share Analysis, 2023
18.2.2.1. By Product
18.2.2.2. By Sample
18.2.2.3. By Mode of Purchase
18.2.2.4. By Application
18.2.2.5. By End User
18.3. Brazil
18.3.1. Pricing Analysis
18.3.2. Market Share Analysis, 2023
18.3.2.1. By Product
18.3.2.2. By Sample
18.3.2.3. By Mode of Purchase
18.3.2.4. By Application
18.3.2.5. By End User
18.4. Mexico
18.4.1. Pricing Analysis
18.4.2. Market Share Analysis, 2023
18.4.2.1. By Product
18.4.2.2. By Sample
18.4.2.3. By Mode of Purchase
18.4.2.4. By Application
18.4.2.5. By End User
18.5. Germany
18.5.1. Pricing Analysis
18.5.2. Market Share Analysis, 2023
18.5.2.1. By Product
18.5.2.2. By Sample
18.5.2.3. By Mode of Purchase
18.5.2.4. By Application
18.5.2.5. By End User
18.6. UK
18.6.1. Pricing Analysis
18.6.2. Market Share Analysis, 2023
18.6.2.1. By Product
18.6.2.2. By Sample
18.6.2.3. By Mode of Purchase
18.6.2.4. By Application
18.6.2.5. By End User
18.7. France
18.7.1. Pricing Analysis
18.7.2. Market Share Analysis, 2023
18.7.2.1. By Product
18.7.2.2. By Sample
18.7.2.3. By Mode of Purchase
18.7.2.4. By Application
18.7.2.5. By End User
18.8. Spain
18.8.1. Pricing Analysis
18.8.2. Market Share Analysis, 2023
18.8.2.1. By Product
18.8.2.2. By Sample
18.8.2.3. By Mode of Purchase
18.8.2.4. By Application
18.8.2.5. By End User
18.9. Italy
18.9.1. Pricing Analysis
18.9.2. Market Share Analysis, 2023
18.9.2.1. By Product
18.9.2.2. By Sample
18.9.2.3. By Mode of Purchase
18.9.2.4. By Application
18.9.2.5. By End User
18.10. Poland
18.10.1. Pricing Analysis
18.10.2. Market Share Analysis, 2023
18.10.2.1. By Product
18.10.2.2. By Sample
18.10.2.3. By Mode of Purchase
18.10.2.4. By Application
18.10.2.5. By End User
18.11. Russia
18.11.1. Pricing Analysis
18.11.2. Market Share Analysis, 2023
18.11.2.1. By Product
18.11.2.2. By Sample
18.11.2.3. By Mode of Purchase
18.11.2.4. By Application
18.11.2.5. By End User
18.12. Czech Republic
18.12.1. Pricing Analysis
18.12.2. Market Share Analysis, 2023
18.12.2.1. By Product
18.12.2.2. By Sample
18.12.2.3. By Mode of Purchase
18.12.2.4. By Application
18.12.2.5. By End User
18.13. Romania
18.13.1. Pricing Analysis
18.13.2. Market Share Analysis, 2023
18.13.2.1. By Product
18.13.2.2. By Sample
18.13.2.3. By Mode of Purchase
18.13.2.4. By Application
18.13.2.5. By End User
18.14. India
18.14.1. Pricing Analysis
18.14.2. Market Share Analysis, 2023
18.14.2.1. By Product
18.14.2.2. By Sample
18.14.2.3. By Mode of Purchase
18.14.2.4. By Application
18.14.2.5. By End User
18.15. Bangladesh
18.15.1. Pricing Analysis
18.15.2. Market Share Analysis, 2023
18.15.2.1. By Product
18.15.2.2. By Sample
18.15.2.3. By Mode of Purchase
18.15.2.4. By Application
18.15.2.5. By End User
18.16. Australia
18.16.1. Pricing Analysis
18.16.2. Market Share Analysis, 2023
18.16.2.1. By Product
18.16.2.2. By Sample
18.16.2.3. By Mode of Purchase
18.16.2.4. By Application
18.16.2.5. By End User
18.17. New Zealand
18.17.1. Pricing Analysis
18.17.2. Market Share Analysis, 2023
18.17.2.1. By Product
18.17.2.2. By Sample
18.17.2.3. By Mode of Purchase
18.17.2.4. By Application
18.17.2.5. By End User
18.18. China
18.18.1. Pricing Analysis
18.18.2. Market Share Analysis, 2023
18.18.2.1. By Product
18.18.2.2. By Sample
18.18.2.3. By Mode of Purchase
18.18.2.4. By Application
18.18.2.5. By End User
18.19. Japan
18.19.1. Pricing Analysis
18.19.2. Market Share Analysis, 2023
18.19.2.1. By Product
18.19.2.2. By Sample
18.19.2.3. By Mode of Purchase
18.19.2.4. By Application
18.19.2.5. By End User
18.20. South Korea
18.20.1. Pricing Analysis
18.20.2. Market Share Analysis, 2023
18.20.2.1. By Product
18.20.2.2. By Sample
18.20.2.3. By Mode of Purchase
18.20.2.4. By Application
18.20.2.5. By End User
18.21. GCC Countries
18.21.1. Pricing Analysis
18.21.2. Market Share Analysis, 2023
18.21.2.1. By Product
18.21.2.2. By Sample
18.21.2.3. By Mode of Purchase
18.21.2.4. By Application
18.21.2.5. By End User
18.22. South Africa
18.22.1. Pricing Analysis
18.22.2. Market Share Analysis, 2023
18.22.2.1. By Product
18.22.2.2. By Sample
18.22.2.3. By Mode of Purchase
18.22.2.4. By Application
18.22.2.5. By End User
18.23. Israel
18.23.1. Pricing Analysis
18.23.2. Market Share Analysis, 2023
18.23.2.1. By Product
18.23.2.2. By Sample
18.23.2.3. By Mode of Purchase
18.23.2.4. By Application
18.23.2.5. By End User
19. Market Structure Analysis
19.1. Competition Dashboard
19.2. Competition Benchmarking
19.3. Market Share Analysis of Top Players
19.3.1. By Regional
19.3.2. By Product
19.3.3. By Sample
19.3.4. By Mode of Purchase
19.3.5. By Application
19.3.6. By End User
20. Competition Analysis
20.1. Competition Deep Dive
20.1.1. AdvaCare Pharma - (USA)
20.1.1.1. Overview
20.1.1.2. Product Portfolio
20.1.1.3. Profitability by Market Segments
20.1.1.4. Sales Footprint
20.1.1.5. Strategy Overview
20.1.1.5.1. Marketing Strategy
20.1.2. Prestige Consumer Healthcare, Inc. (USA)
20.1.2.1. Overview
20.1.2.2. Product Portfolio
20.1.2.3. Profitability by Market Segments
20.1.2.4. Sales Footprint
20.1.2.5. Strategy Overview
20.1.2.5.1. Marketing Strategy
20.1.3. Babystart - (USA)
20.1.3.1. Overview
20.1.3.2. Product Portfolio
20.1.3.3. Profitability by Market Segments
20.1.3.4. Sales Footprint
20.1.3.5. Strategy Overview
20.1.3.5.1. Marketing Strategy
20.1.4. Fertility Focus Limited (UK)
20.1.4.1. Overview
20.1.4.2. Product Portfolio
20.1.4.3. Profitability by Market Segments
20.1.4.4. Sales Footprint
20.1.4.5. Strategy Overview
20.1.4.5.1. Marketing Strategy
20.1.5. bioZhena Corporation - (USA)
20.1.5.1. Overview
20.1.5.2. Product Portfolio
20.1.5.3. Profitability by Market Segments
20.1.5.4. Sales Footprint
20.1.5.5. Strategy Overview
20.1.5.5.1. Marketing Strategy
20.1.6. Prestige Consumer Healthcare, Inc. (USA)
20.1.6.1. Overview
20.1.6.2. Product Portfolio
20.1.6.3. Profitability by Market Segments
20.1.6.4. Sales Footprint
20.1.6.5. Strategy Overview
20.1.6.5.1. Marketing Strategy
20.1.7. Church & Dwight Co., Inc. (USA)
20.1.7.1. Overview
20.1.7.2. Product Portfolio
20.1.7.3. Profitability by Market Segments
20.1.7.4. Sales Footprint
20.1.7.5. Strategy Overview
20.1.7.5.1. Marketing Strategy
20.1.8. UEBE Medical GmbH (Germany)
20.1.8.1. Overview
20.1.8.2. Product Portfolio
20.1.8.3. Profitability by Market Segments
20.1.8.4. Sales Footprint
20.1.8.5. Strategy Overview
20.1.8.5.1. Marketing Strategy
20.1.9. Geratherm Medical AG (Germany)
20.1.9.1. Overview
20.1.9.2. Product Portfolio
20.1.9.3. Profitability by Market Segments
20.1.9.4. Sales Footprint
20.1.9.5. Strategy Overview
20.1.9.5.1. Marketing Strategy
20.1.10. Valley Electronics AG (Switzerland)
20.1.10.1. Overview
20.1.10.2. Product Portfolio
20.1.10.3. Profitability by Market Segments
20.1.10.4. Sales Footprint
20.1.10.5. Strategy Overview
20.1.10.5.1. Marketing Strategy
20.1.11. Geratherm Medical AG (Germany)
20.1.11.1. Overview
20.1.11.2. Product Portfolio
20.1.11.3. Profitability by Market Segments
20.1.11.4. Sales Footprint
20.1.11.5. Strategy Overview
20.1.11.5.1. Marketing Strategy
21. Assumptions & Acronyms Used
22. Research Methodology
Explore Healthcare Insights
View Reports